FUJIFILM Processor EP-8000;Balloon Controller PB-30;Endoscopy Support Program EW10-VM01

K261880 · Fujifilm Corporation · FET · Jul 2, 2026 · Gastroenterology, Urology

Device Facts

Record IDK261880
Device NameFUJIFILM Processor EP-8000;Balloon Controller PB-30;Endoscopy Support Program EW10-VM01
ApplicantFujifilm Corporation
Product CodeFET · Gastroenterology, Urology
Decision DateJul 2, 2026
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 876.1500
Device ClassClass 2

Indications for Use

Processor EP-8000 The EP-8000 is an endoscopic processor with an integrated light source that is intended to provide illumination, process electronic signals transmitted from a video endoscope and enable image recording. This product can be used in combination with compatible medical endoscope, a monitor, a recorder and various peripherals. It supplies air through the endoscope, for obtaining clear visualization and is used for endoscopic observation, diagnosis and treatment. BLI (Blue Light Imaging), LCI (Linked Color Imaging), ACI (Amber-red Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examinations which can be used to supplement Fujifilm white light endoscopy. BLI, LCI, ACI and FICE are not intended to replace histopathological sampling as a means of diagnosis. PB-30 This product is a balloon pump apparatus intended to inflate or deflate a balloon to assist with endoscope and over-tube insertion. This product is not intended for use for any neonates, infants or children. EW10-VM01 This software provides image information to assist the user in estimating the size of an object displayed in the endoscopic field of view. This software provides no therapeutic or diagnostic function.

Device Story

System comprises EP-8000 processor, PB-30 balloon controller, and EW10-VM01 support software. EP-8000 provides LED illumination (violet, blue, green, amber) and processes CMOS sensor signals from endoscopes into video for monitor display; supports BLI, LCI, ACI, and FICE imaging modes. PB-30 acts as a balloon pump, using solenoid valves and pressure sensors to inflate/deflate balloons on endoscopes/over-tubes to assist insertion. EW10-VM01 software runs on a PC connected via DVI/RS-232C; overlays a 'Virtual Scale' on the endoscopic video feed to assist user in estimating object size. Used in clinical settings by physicians; output aids in visualization, diagnosis, and procedural navigation. System updates include new device combinations and OS support, verified via compatibility and design testing.

Clinical Evidence

Bench testing only. Compatibility testing was conducted for the new combinations of the EP-8000, PB-30, and EW10-VM01. Design verification was performed for software updates and new operating system support. No clinical data was required or provided.

Technological Characteristics

EP-8000: Steel-polycarbonate housing (395x210x515mm), 4-LED light source (79.2W), AC powered (100-240V). PB-30: Balloon pump with solenoid valves, pressure sensors, and remote switch (RC-30). EW10-VM01: PC-based software, DVI/RS-232C connectivity. System uses fiber bundles for light transmission and CMOS sensors for imaging. Software provides non-diagnostic/non-therapeutic image overlay (Virtual Scale).

Indications for Use

Indicated for adults (22+ years) undergoing gastrointestinal endoscopic observation, diagnosis, and treatment using the EP-8000 processor. The PB-30 balloon controller is indicated for balloon inflation/deflation to assist endoscope/over-tube insertion in adults; contraindicated for neonates, infants, and children. The EW10-VM01 software is indicated for estimating object size in the endoscopic field of view.

Regulatory Classification

Identification

An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

Special Controls

*Classification* —(1)*Class II (special controls).* The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.

In combination with the general controls of the FD&C Act, the integrated operating table-electromechanical surgical system is subject to the following special controls: 1. (1) Premarket clinical performance testing, or a combination of premarket clinical performance testing and postmarket surveillance (in accordance with special control (2)), must include the following: 1. (i) Objective performance measures (e.g., rate and number of conversions to other surgical modalities, rate of device related adverse events (including tissue injury, hematoma, and increased blood loss), and their severity, cause, and outcomes) must be reported with relevant descriptive comparator performance measures. 2. (ii) The data must demonstrate the performance of the device for providing accurate and precise control of attached surgical instruments in range of clinical conditions relevant to the device's intended use. 3. (iii) The test dataset must include data collected from a patient population representative of the intended patient population under anticipated conditions of use. 2. (2) Data obtained from postmarket surveillance must demonstrate, in consideration of the premarket data obtained in accordance with special control (1), that the device performs in accordance with special control (1), unless FDA determines, based on the totality of the premarket data, that data from postmarket surveillance is not required to demonstrate that the device performs as intended. Such postmarket surveillance must be conducted per a protocol determined appropriate by FDA to demonstrate that the device performs as intended (in consideration of the premarket data obtained in accordance with special control (1)), and must include initiation, enrollment, and reporting requirements to ensure timely periodic updates to FDA on post-market surveillance progress and outcomes. 3. (3) Animal performance testing must evaluate the extent of port site trauma due to repositioning of table during surgical procedures when utilizing robotic minimally invasive and laparoscopic approaches 4. (4) The device manufacturer must develop, and update as necessary, a device-specific use training program that ensures proper device setup/use/shutdown, accurate control of instruments to perform the intended surgical procedures, troubleshooting and handling during unexpected events or emergencies, and safe practices to mitigate use error. 5. (5) The device manufacturer may only distribute the device to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program. (6) Human factors assessment must demonstrate that the user can correctly use the device system across all intended use environments with the provided instructions and training materials, including patient access during normal operating conditions and emergency situations, and effects arising from the integrated nature of the operating table and robotic surgical arms. (7) Labeling must include: (i) A detailed summary of clinical performance testing conducted with the device, including study population, results, adverse events, and comparisons to any comparator groups identified; (ii) A statement in the labeling that the safety and effectiveness for the representative specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of the patient's underlying disease or condition, unless FDA determines that it can be removed or modified based on clinical performance data submitted to FDA; (iii) Identification of compatible devices; (iv) The list of surgical procedures for which the device has been determined to be safe with clinical justification; (v) Reprocessing instructions for reusable components; (vi) A shelf life for any sterile components; (vii) A description of the device-specific use training program; (viii) A statement that the device is only for distribution to facilities that implement and maintain the device-specific use training program and ensure that users of the device have completed the device-specific use training program; and (ix) A summary of any completed postmarket surveillance data collected as required by special control (2), including updated labeling to accurately reflect outcomes observed in postmarket surveillance. (8) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use and must include: (i) Device motion accuracy and repeatability; (ii) System testing; (iii) Instrument reliability; (iv) Crosstalk; (v) Table motion control; (vi) Thermal effects on tissue; (vii) User-device interface performance; (viii) Workspace access testing; and (ix) Performance testing with compatible devices. (9) Software verification, validation, and hazard analysis must be performed. (10) Electromagnetic compatibility and electrical, thermal, and mechanical safety testing must be performed. (11) Performance data must demonstrate the sterility of all patient-contacting device components. (12) Performance data must support the shelf life of the device components provided sterile by demonstrating continued sterility and package integrity over the labeled shelf life. (13) Performance data must validate the reprocessing instructions for the reusable components of the device. (14) Performance data must demonstrate that all patient-contacting components of the device are biocompatible. (15) Performance data must demonstrate that all patient-contacting components of the device are non-pyrogenic. (16) The device manufacturer must submit a report to the FDA annually on the anniversary of initial marketing authorization for the device, until such time as FDA may terminate such reporting, which comprises the following information: (i) Cumulative summary, by year, of complaints and adverse events since date of initial marketing authorization; and (ii) Identification and rationale for changes made to the device, labeling, or device specific use training program, which did not require submission of a premarket notification during the reporting period.

Predicate Devices

Submission Summary (Full Text)

{0} ![LOGO](U.S. Food & Drug Administration) July 2, 2026 Fujifilm Corporation % Chaitrali Kulkarni Sr. Regulatory Affairs Specialist FUJIFILM Healthcare Americas Corporation 81 Hartwell Ave. Suite 100 Lexington, Massachusetts 02421 Re: K261880 Trade/Device Name: FUJIFILM Processor EP-8000;Balloon Controller PB-30;Endoscopy Support Program EW10-VM01 Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope And Accessories Regulatory Class: Class II Product Code: FET, NTN, NWB, PEA, FDF, FDA, QTH Dated: June 5, 2026 Received: June 5, 2026 Dear Chaitrali Kulkarni: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K261880 - Chaitrali Kulkarni Page 2 Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory- {2} K261880 - Chaitrali Kulkarni Page 3 assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, SHANIL P. HAUGEN -S Shanil P. Haugen, Ph.D. Assistant Director DHT3A: Division of Renal, Gastrointestinal, Obesity and Transplant Devices OHT3: Office of Gastrorenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} # Indications for Use | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K261880 | ? | | --- | --- | --- | | Please provide the device trade name(s). | | ? | | FUJIFILM Processor EP-8000; Balloon Controller PB-30; Endoscopy Support Program EW10-VM01 | | | | Please provide your Indications for Use below. | | ? | | Processor EP-8000 The EP-8000 is an endoscopic processor with an integrated light source that is intended to provide illumination, process electronic signals transmitted from a video endoscope and enable image recording. This product can be used in combination with compatible medical endoscope, a monitor, a recorder and various peripherals. It supplies air through the endoscope, for obtaining clear visualization and is used for endoscopic observation, diagnosis and treatment. BLI (Blue Light Imaging), LCI (Linked Color Imaging), ACI (Amber-red Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examinations which can be used to supplement Fujifilm white light endoscopy. BLI, LCI, ACI and FICE are not intended to replace histopathological sampling as a means of diagnosis. PB-30 This product is a balloon pump apparatus intended to inflate or deflate a balloon to assist with endoscope and over-tube insertion. This product is not intended for use for any neonates, infants or children. EW10-VM01 This software provides image information to assist the user in estimating the size of an object displayed in the endoscopic field of view. This software provides no therapeutic or diagnostic function. | | | | Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | | Please select the age group(s) for which the device(s) is to be used. | ☐ Neonates/Newborns (Birth to < 29 days old) ☐ Infants (29 days old to < 2 years old) ☐ Children (2 years old to < 12 years old) ☐ Adolescents (12 years old to < 22 years old) ☑ Adults (22 years old and greater) | ? | {4} K261880 page 1/3 510(k) #: # 510(k) Summary Prepared on: 2026-06-05 Contact Details 21 CFR 807.92(a)(1) | Applicant Name | FUJIFILM Corporation | | --- | --- | | Applicant Address | 798 Miyanodai Kaise-Machi Ashigarakami-Gun Kanagawa 258-8538 Japan | | Applicant Contact Telephone | 704-517-4886 | | Applicant Contact | Ms. Chaitrali Kulkarni | | Applicant Contact Email | hcusregulatoryaffairs@fujifilm.com | | Correspondent Name | FUJIFILM Healthcare Americas Corporation | | Correspondent Address | 81 Hartwell Ave. Suite 100 Lexington MA 02421 United States | | Correspondent Contact Telephone | 704-517-4886 | | Correspondent Contact | Ms. Chaitrali Kulkarni | | Correspondent Contact Email | hcusregulatoryaffairs@fujifilm.com | Device Name 21 CFR 807.92(a)(2) | Device Trade Name | FUJIFILM Processor EP-8000; Balloon Controller PB-30; Endoscopy Support Program EW10-VM01 | | --- | --- | | Common Name | Endoscopic Video Imaging System/Component, Gastroenterology-Urology | | Classification Name | Endoscope and accessories | | Regulation Number | 876.1500 | | Product Code(s) | FET, NTN,NWB,PEA,FDF,FDA,QTH | Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) | Predicate # | Predicate Trade Name (Primary Predicate is listed first) | Product Code | | --- | --- | --- | | K243260 | FUJIFILM Processor EP-8000; FUJIFILM Endoscope Model EG-860R | FET | | K153483 | Balloon controller PB-30 | FDF | | K223827 | FUJIFILM Endoscope Model EC-760S-A/L, Endoscopy Support Program EW10-VM01 | FDF | Device Description Summary 21 CFR 807.92(a)(4) {5} K261880 pg 2/3 # Processor EP-8000 # A. Intended Use/indications for Use The EP-8000 is an endoscopic processor with an integrated light source that is intended to provide illumination, process electronic signals transmitted from a video endoscope and enable image recording. This product can be used in combination with compatible medical endoscope, a monitor, a recorder and various peripherals. It supplies air through the endoscope, for obtaining clear visualization and is used for endoscopic observation, diagnosis and treatment. BLI (Blue Light Imaging), LCI (Linked Color Imaging), ACI (Amber-red Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examinations which can be used to supplement Fujifilm white light endoscopy. BLI, LCI, ACI and FICE are not intended to replace histopathological sampling as a means of diagnosis. # B. Technological characteristics FUJIFILM Video Processor EP-8000 is intended to provide illumination, process electronic signals transmitted from a video endoscope and enable image recording. FUJIFILM Video Processor EP-8000 relays the image from an endoscope to a video monitor. The projection can be either analog or digital at the user's preference. The processor employs fiber bundles to transmit light from four LED lamps (Violet, Blue, Green, and Amber), with a total power of 79.2W lamps, to the body cavity. The device is AC operated at a power setting of 100-240V/50-60Hz/ 3.0-1.5A. The processor is housed in a steel-polycarbonate case measuring 395x210x515mm # C. Principles of Operation The subject device, FUJIFILM Video Processor EP-8000, combines the principles of operation of the predicate devices, FUJIFILM Video Processor VP-7000 and Light Source BL-7000. EP-8000 is intended to provide illumination, process electronic signals transmitted from a video endoscope during the endoscopic observation, diagnosis, treatment, and image recording. After connecting to the light source and processor, the devices guide the light through the fiber bundles situated inside the insertion portion of the device. The light that emits from the distal end of the insertion portion reflects from the target region and forms an image on the CMOS image sensor through a group of object lenses placed at the distal end of the devices. An electric signal from the image sensor is transmitted to the video processor connected to the device. The video processor converts the electric signal into a video signal and displays an image on a monitor. # PB-30 # A. Intended Use/indications for Use This product is a balloon pump apparatus intended to inflate or deflate a balloon to assist with endoscope and over-tube insertion. This product is not intended for use for any neonates, infants or children. # B. Technological characteristics By connecting this product and the EN-840T double-balloon endoscope to the EP-8000 processor, the functions of the toggle switch 1, toggle switch 2 and stop switch on the PB-30 remote switch (RC-30) can be assigned to the scope switches. # C. Principles of Operation This product activates the air feed pump unit in the main unit to feed air into the balloon attached to the ENDOSCOPE or into the balloon attached to the overtube via the solenoid valve unit and the tube kit connected to the main unit. Similarly, this product activates the air evacuation unit to evacuate air from the balloon. By activating the solenoid valve unit, the channel between the tube kit and the air feed pump or the channel between the tube kit and the air evacuation pump is opened and closed to switch balloon air feed and balloon air evacuation. A pressure sensor located in the channel between the solenoid valve unit and the balloon monitors the air pressure inside the balloon and controls the solenoid valve unit according to the presetting pressure. The distal end of ENDOSCOPE and the distal end of overtube can be fixed to the digestive tract by inflating the balloon at the presetting pressure. Insertion of the ENDOSCOPE into the digestive tract is assisted by repeating air feed and air evacuation to inflate and deflate the balloon on the ENDOSCOPE side and the one on the overtube side in turn to advance the ENDOSCOPE in the body cavity. # EW10-VM01 # A. Intended Use/indications for Use This software provides image information to assist the user in estimating the size of an object displayed in the endoscopic field of view. This software provides no therapeutic or diagnostic function. # B. Technological characteristics This device is used in combination with light source device, processor, medical endoscope, monitor, recording device, and peripheral device. It is an endoscopic examination supporting program for the purpose of diagnostic support. The device can be connected to EP-8000 processor / light source integrated and BL-7000 light source, VP-7000 processor. In the case of the EC-760S-A/L system endoscope, Virtual Scale display function is enabled. {6} K261880 pg 3/3 C. Principles of Operation The Personal Computer in which the endoscopy support program is installed and the processor is connected with a DVI cable and an RS-232C cable. An endoscopic movie received from an endoscope processor through a DVI cable, and a movie in which the Virtual Scale result is superimposed on the endoscopic movie is output to a monitor. The Virtual Scale display function accepts the user operation by the switch of the medical endoscope, and the operation signal is input from the endoscope processor to the endoscopic examination supporting program through the RS-232C cable. ## Intended Use/Indications for Use 21 CFR 807.92(a)(5) Processor EP-8000 The EP-8000 is an endoscopic processor with an integrated light source that is intended to provide illumination, process electronic signals transmitted from a video endoscope and enable image recording. This product can be used in combination with compatible medical endoscope, a monitor, a recorder and various peripherals. It supplies air through the endoscope, for obtaining clear visualization and is used for endoscopic observation, diagnosis and treatment. BLI (Blue Light Imaging), LCI (Linked Color Imaging), ACI (Amber-red Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examinations which can be used to supplement Fujifilm white light endoscopy. BLI, LCI, ACI and FICE are not intended to replace histopathological sampling as a means of diagnosis. PB-30 This product is a balloon pump apparatus intended to inflate or deflate a balloon to assist with endoscope and over-tube insertion. This product is not intended for use for any neonates, infants or children. EW10-VM01 This software provides image information to assist the user in estimating the size of an object displayed in the endoscopic field of view. This software provides no therapeutic or diagnostic function. ## Indications for Use Comparison 21 CFR 807.92(a)(5) The indication for use for the proposed device and the predicate devices are same. ## Technological Comparison 21 CFR 807.92(a)(6) EP-8000 This update adds the combination of the Endoscopy Support Program EW10-VM01, Expansion Unit Base Software EW10-SC01 and the balloon controller PB-30. There are no other changes to the technical specifications. We have conducted compatibility testing for this combination, and it does not affect the safety or efficacy of the proposed model. PB-30 Change the applicable endoscopes but it was confirmed that electromagnetic compatibility with combination devices. And Change the applicable over-tubes but it has been tested in combination with the TS-1314B. Change the combination with connecting tubes, but it has been tested in combination with the TY-500D. As for these changes of the combinations, this device and combination devices were confirmed that as intended to can be operated safely based on the above standards. Software Update but his it was confirmed that as intended to can be operated safely based on software test. EW10-VM01 EP-8000 add the combination of processor but combination verification was conducted on the additional equipment, and it was confirmed that there was no impact on the intended functions, performance, safety, efficacy, etc. of this software. Add the supports OS but the design verification was conducted in the operating environment to be added, and it was confirmed that there was no impact on the intended functions, performance, safety, effectiveness, etc. of this software. ## Non-Clinical and/or Clinical Tests Summary & Conclusions 21 CFR 807.92(b) This update adds the combination of the endoscope support program EW10-VM01 and the PB-30 balloon controller PB-30. There are no other changes to the technical specifications. We have conducted compatibility testing for this combination, and it does not affect the safety or efficacy of the proposed model.
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...